The Role, Potential Benefits and Cost-effectiveness of Digital Tools for Diabetes Management
Authors:
Open Access
- 9 June 2025
- journal article
- review article
- Published by Elsevier in Clinical Therapeutics
- Vol. 47 (8) , 638-648
Abstract
No abstract availableKeywords
Funding Information
- Novo Nordisk A/S
This publication has 91 references indexed in Scilit:
- Automated insulin delivery: benefits, challenges, and recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes AssociationDiabetologia, 2022
- The consequences of hypoglycaemiaDiabetologia, 2021
- Evaluation of the Clinical and Economic Burden of Poor Glycemic Control Associated with Therapeutic Inertia in Patients with Type 2 Diabetes in the United StatesAdvances in Therapy, 2020
- Comparative risk of serious hypoglycemia with oral antidiabetic monotherapy: A retrospective cohort studyPharmacoepidemiology and Drug Safety, 2017
- Overtreatment and Deintensification of Diabetic Therapy among Medicare BeneficiariesJournal of General Internal Medicine, 2017
- Role of Mobile Technology to Improve Diabetes Care in Adults with Type 1 Diabetes: The Remote-T1D Study iBGStar® in Type 1 Diabetes ManagementDiabetes Therapy, 2017
- Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin InjectionsJAMA, 2017
- Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 DiabetesJAMA, 2016
- Experiences of People with Diabetes by Payer Type: An Analysis of the Roper Diabetes Data SetDiabetes Therapy, 2015
- Glycaemic impact of patient-led use of sensor-guided pump therapy in type 1 diabetes: a randomised controlled trialDiabetologia, 2009